ADVERTISEMENT
Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said on Tuesday, as he promised similar deals with other drugmakers under the threat of tariffs.
Trump made the announcement at the White House alongside Pfizer CEO Albert Bourla just hours ahead of a government shutdown in a partisan standoff over healthcare and spending.
Pfizer, one of the largest US drugmakers, produces the COVID-19 vaccine Comirnaty and the treatment Paxlovid. Its products also include several cancer drugs, the blood thinner Eliquis, and Prevnar pneumonia vaccines.
Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly lau
Continue Reading on Euronews
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.